PubMed Health treatment related to Oral Candidiasis: 63
Oral thrush can be treated with antimycotics. These are available as drugs that produce either a topical (local) or a systemic (throughout the whole body) effect. Medication that acts in both ways is also an option. The type of medication that is best suited for someone with a weakened immune system will depend on their individual situation.
Drugs for Oral Candidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 141)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Fluticasone |
Approved, Experimental |
Phase 4 |
|
90566-53-3 |
4659387 5311101 |
Synonyms:
ADVAIR
Advair®|Avamys®|Flovent HFA®|Veramyst®
FLOVENT HFA
Fluticason
|
Fluticasona
Fluticasone
Fluticasonum
VERAMYST
|
|
2 |
|
Nystatin |
Approved, Vet_approved |
Phase 4 |
|
1400-61-9 |
11953884 |
Synonyms:
ABBR nyt
BARSTATIN 100
CANDEX
INFESTAT
KOROSTATIN
MULTILIND
MYCO 20
Mycostatin
MYKINAC
NILSTAT
Nistatina
NSC-150817
|
NYS
NYSERT
NYSPES
NYSTAFORM
NYSTAN TRIPLE PACK
Nystatin
Nystatine
Nystatinum
NYSTAVESCENT
NYSTEX
NYSTOP
TINADERM M
|
|
3 |
|
Amphotericin B |
Approved, Investigational |
Phase 4 |
|
1397-89-3 |
5280965 |
Synonyms:
ABBR amb
ABELCET
Ambisome
Amfotericina b
AMOPHOTERICIN B
AMPH-b
Amphocil
AMPHO-MORONAL
Amphortericin b
Amphotec
AMPHOTERCIN B
Amphotericin
AMPHOTERICIN B
Amphotericin b cholesterol dispersion
Amphotericin b colloidal dispersion
|
AMPHOTERICIN B LIPID COMPLEX
AMPHOTERICIN B LIPOSOMAL COMPLEX
Amphotericine b
AMPHOTÉRICINE B
Amphotericinum b
AMPHOTERICITIN B
AMPHOTREICIN B
AMPOTERICIN B
APT370
C-AMB
FUNGILIN
FUNGILIN IN ORABASE
Fungizone
Liposomal amphotericin b
NSC-527017
|
|
4 |
|
Voriconazole |
Approved |
Phase 4 |
|
137234-62-9 |
71616 |
Synonyms:
(AlphaR,betas)-a-(2,4-difluorophenyl)-5-fluoro-b-methyl-a(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(AlphaR,betas)-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-a-(2,4-difluorophenyl)-5-fluoro-b-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(αR,βS)-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
|
UK-109496
VCZ
Vfend
Voriconazol
Voriconazole
Voriconazolum
|
|
5 |
|
Dequalinium |
Approved, Investigational |
Phase 4 |
|
6707-58-0 |
2993 |
Synonyms:
1,1'-(1,10-Decanediyl)bis(4-amino-2-methylquinolinium) dichloride
1,1'-Decamethylenebis(4-aminoquinaldinium chloride)
|
Decamethylenebis(4-aminoquinaldinium chloride)
DEQUALINIUM
|
|
6 |
|
Terconazole |
Approved |
Phase 4 |
|
67915-31-5 |
441383 |
Synonyms:
1-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)piperazine
Cilag brand OF terconazole
Fungistat
Gyno-terazol
Janssen brand OF terconazole
NSC-331942
Ortho brand OF terconazole
PANLOMYC
|
R 42470
R-42470
Terazol
Terazol 3
TERAZOL 7
Terconazole
Triaconazole
|
|
7 |
|
Clindamycin |
Approved, Vet_approved |
Phase 4 |
|
18323-44-9, 24729-96-2 |
29029 |
Synonyms:
7 Chloro 7 deoxylincomycin
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
ANTIROBE
Chlolincocin
Chlorlincocin
CHLORODEOXYLINCOMYCIN
CHLOROLINCOMYCIN
CLDM
Cleocin
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
CLEOCIN T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
Clinda-Derm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
CLINDAMYCIN
Clindamycin Hcl
Clindamycin hydrochloride
Clindamycin monohydrochloride
Clindamycin monohydrochloride, monohydrate
|
Clindamycin phosphate
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Evoclin
Hydrochloride, clindamycin
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside
Monohydrate clindamycin monohydrochloride
Monohydrochloride, clindamycin
Monohydrochloride, monohydrate clindamycin
ResiDerm A
SOBELIN
U-21251
Zindaclin
|
|
8 |
|
Hydrocortisone succinate |
Approved |
Phase 4 |
|
2203-97-6 |
3643 |
Synonyms:
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
Cortisol 21-(hydrogen succinate)
Cortisol succinate
HYDROCORTISONE HEMISUCCINATE
|
Hydrocortisone hemisuccinate anhydrous
Hydrocortisone hydrogen succinate
HYDROCORTISONE SUCCINATE
Hydroxycortisone succinate
NSC-7576
|
|
9 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 4 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
BARQUINOL HC
CHLOROMYCETIN HYDROCORT
COLIFOAM
CORTEF ACETATE
CORTIFOAM
Cortisol 21-acetate
CORTRIL
CORTUCID
DRICORT
EPIFOAM
FRAMYCORT
FUCIDIN H
GENTICIN HC
GENTISONE HC
|
GPPE EAR SUSP
GPPE EYE CRM
GPPE FOAM AERO
HC45 HYDROCORT
HEMSOL-HC
HEPACORT PLUS
HYDROCAL
HYDROCORTISONE 21-ACETATE
HYDROCORTISONE ACETATE
HYDROCORTONE
LANACORT
MICORT-HC
NEO-CORTEF
NSC-741
ORABASE HCA
|
|
10 |
|
Hydrocortisone |
Approved, Vet_approved |
Phase 4 |
|
50-23-7 |
3640 5754 |
Synonyms:
(11ALPHA,14BETA)-11,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE
(11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11Β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(1S,2R,10S,11S,14S,15S,17S)-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
11 Epicortisol
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b,17a,21-Trihydroxy-4-pregnene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11-beta-Hydrocortisone
11beta-Hydroxycortisone
11-beta-Hydroxycortisone
11b-Hydrocortisone
11b-Hydroxycortisone
11-Epicortisol
11-Hydrocortisone
11Β,17α,21-trihydroxy-4-pregnene-3,20-dione
11Β-hydrocortisone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
17-Hydroxycorticosterone
4-Pregnen-11b,17a,21-triol-3,20-dione
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnen-11β,17α,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
ACETASOL HC
ACTICO МИХАИЛRT
Acticort
Acticort®|Efmody®|Plenadren®
Aeroseb HC
Aeroseb-HC
Alacort
Ala-cort
Ala-scalp
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort-HC
ANUGESIC HC
Anusol HC
ANUSOL PLUS HC
ANUSOL SOOTHING RELIEF
Anusol-HC
Aquacort
Aquanil HC
Balneol-HC
Barseb HC
Basan-corti
Beta-HC
b-HC
CaldeCORT spray
CALMURID HC
CANESTEN HC
Cetacort
Chronocort
CIPRO HC
Clear aid
Cleiton
Cobadex
Colocort
Compound F
CORLAN
Cor-oticin
Cortanal
Cor-tar-quin
Cort-dome
Cortef
CORTENEM
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisolonum
Cortisporin
Cortisporin otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cort-quin
CORTRIL
Cremesone
Cremicort-H
Cutisol
DAKTACORT
DAKTACORT HYDROCORT
Delacort
DERMA CARE HYDROCORT
Dermacort
Derm-aid
DERMASPRAY DEMANG
Dermil
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
ECONACORT
Ef corlin
Efcorbin
Efcortelan
EFCORTELAN P
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
EURAX-HC
EURAX-HYDROCORT
Evacort
EXE-CORT
Ficortril
Fiocortril
Flexicort
Foille insetti
Genacort
GERMOLOIDS HC
Glycort
GREGODERM
gyno-Cortisone
HC
|
HC #1
HC #4
HC (HYDROCORTISONE)
HC45
H-Cort
Heb cort
Heb-cort
Hi-cor
Hidalone
hidro-Colisona
Hidrocortisona
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
hydro-Adreson
hydro-Colisona
Hydrocort
HYDROCORT IN CALAMINE OILY
HYDROCORT IN CETOMACROGOL FOR A
HYDROCORT IN WTE SOFT PARAF
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone butyrate
Hydrocortisone free alcohol
Hydrocortisone in absorbase
Hydrocortisone sodium phosphate
Hydrocortisone valerate
Hydrocortisone, (11 alpha)-isomer
Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer
Hydrocortisonum
Hydrocortistab
Hydrocortisyl
HYDROCORTONE
HYDRODERM
HYDRODERM HC
hydro-RX
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone lotion
Idrocortisone
Incortin-H
Incortin-hydrogen
JUNGLE FOR
Kendall's compound F
Komed HC
Kyypakkaus
Lacticare HC
Lacticare-HC
Lactisona
Locoid
Lubricort
Maintasone
Medicort
Meusicort
Micort-HC
Mildison
MILDISON LIPOCREAM
Milliderm
neo-Cort-dome
neo-Cortef
Neosporin-H ear
Nogenic HC
NSC-10483
Nutracort
NYBADEX
Nystaform-HC
Ophthocort
Optef
Otalgine
Otic-neo-cort-dome
Otobiotic
Otocort
OTOSEPTIL
Otosone-F
OTOSPORIN
Pediotic suspension
Penecort
PERINAL
Permicort
Plenadren
Polcort H
Preparation H hydrocortisone cream
Prepcort
Prestwick_265
Prevex HC
Proctocort
PROCTOCREAM HC
Proctofoam
PROCTOFOAM HC
PROCTOSEDYL
Protocort
QUINOCORT
Racet
Rectoid
Reichstein's substance m
Remederm HC
Sanatison
Scalpicin capilar
Schericur
Scheroson F
SENTIAL HC
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral hydrocort
Tarcortin
Terra-cortril
TERRA-CORTRIL NYSTATIN
Texacort
Timocort
TIMODINE
Topicort
TOPISONE
Transderma H
Traumaide
TRI-CICATRIN
U-cort
Uniderm
UNIROID
UNIROID HC
Vioform-hydrocortisone
VoSol HC
Vytone
XYLOPROCT
Zenoxone
β-HC
|
|
11 |
|
Tinidazole |
Approved, Investigational |
Phase 4 |
|
19387-91-8 |
5479 |
Synonyms:
1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitroimidazole
Bioshik
CP-12574
Farmasierra brand OF tinidazole
Fasigin
Fasigyn
Fasigyne
Fasygin
Haisigyn
Pfizer brand OF tinidazole
Pierre fabre brand OF tinidazole
|
Simplotan
SYMPLOTAN
Teofarma brand OF tinidazole
Timidazole
Tindamax
Tinidazol
Tinidazole
Tinidazolum
Tricolam
TRIMONASE
|
|
12 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
13 |
|
Posaconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
171228-49-2 |
147912 |
Synonyms:
|
14 |
|
Fluticasone-Salmeterol Drug Combination |
|
Phase 4 |
|
|
|
15 |
|
Bronchodilator Agents |
|
Phase 4 |
|
|
|
16 |
|
Adrenergic beta-Agonists |
|
Phase 4 |
|
|
|
17 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
18 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
19 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
20 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
21 |
|
Anti-Allergic Agents |
|
Phase 4 |
|
|
|
22 |
|
Xhance |
|
Phase 4 |
|
|
|
23 |
|
Sympathomimetics |
|
Phase 4 |
|
|
|
24 |
|
Salmeterol Xinafoate |
|
Phase 4 |
|
94749-08-3 |
|
Synonyms:
GR-33343 G
GR-33343-G
GR-33343X
LIPO-202
|
SALMETEROL 1-HYDROXY-2-NAPHTHOATE
SALMETEROL XINAFOATE
SEREVENT
|
|
25 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
26 |
|
Cytochrome P-450 CYP3A Inhibitors |
|
Phase 4 |
|
|
|
27 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
28 |
|
Ionophores |
|
Phase 4 |
|
|
|
29 |
|
Antiprotozoal Agents |
|
Phase 4 |
|
|
|
30 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
31 |
|
Liposomal amphotericin B |
|
Phase 4 |
|
|
|
32 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
33 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
34 |
|
Clindamycin phosphate |
|
Phase 4 |
|
|
32603 |
Synonyms:
Cleocin phosphate
Clindamycin phosphoric acid
Clindamycin-2-phosphate
|
|
|
35 |
|
Clindamycin palmitate |
|
Phase 4 |
|
|
|
36 |
|
Liver Extracts |
|
Phase 4 |
|
|
|
37 |
|
Hydrocortisone 17-butyrate 21-propionate |
|
Phase 4 |
|
|
|
38 |
|
Acidophilus |
|
Phase 4 |
|
|
|
39 |
|
Echinocandins |
|
Phase 4 |
|
|
|
40 |
|
Metronidazole |
Approved |
Phase 3 |
|
443-48-1, 69198-10-3 |
4173 |
Synonyms:
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(Β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(Β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(Β-oxyethyl)-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitroimidazole-1-ethanol
ACEA
Acromona
ANABACT
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAY-5360
Bayer 5360
BAYER-5360
Bexon
Clont
Cont
Danizol
Deflamon
Deflamon-Wirkstoff
DRAZIFON
Efloran
ELYZOL
Entizol
Eumin
Flagemona
Flagesol
Flagil
Flagyl
FLAGYL 375
FLAGYL COMPAK
FLAGYL ER
Flagyl I.V.
FLAGYL I.V. RTU IN PLASTIC CONTAINER
FLAGYL-400
FLAGYL-S
Flegyl
Fossyol
Giatricol
Gineflavir
Hydrochloride, metronidazole
Klion
Klont
Meronidal
Methronidazole
Metric
METRIC 21
Metro Cream
Metro I.V.
Metro I.V. In Plastic Container
METRO IV
METROCREAM
Metrodzhil
MetroGel
Metrogel-vaginal
Metrogyl
Metrolag
METROLOTION
METROLYL
|
METROMIDOL
Metronidaz
Metronidazol
METRONIDAZOLE
Métronidazole
Metronidazole benzoate
Metronidazole Hcl
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazolo
Metronidazolum
METROSA
METROTOP
Mexibol
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
Neo-Tric
NEUTRATOP
Nida
Nidagel
Noritate
Noritic acid
NORZOL
Novonidazol
NSC-50364
NSC-69587
NUVESSA
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
PROTOSTAT
Rathimed
ROSICED
ROZEX
RP-8823
Sanatrichom
Satric
Takimetol
Trichazol
Trichex
Tricho Cordes
Trichocide
Tricho-Gynaedron
Trichomol
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
Vagilen
Vagimid
VAGINYL
VANDAZOLE
Vertisal
Wagitran
ZADSTAT
ZIDOVAL
ZYOMET
|
|
41 |
|
Ketoconazole |
Approved, Investigational |
Phase 3 |
|
65277-42-1, 142128-57-2 |
47576 3823 638701 |
Synonyms:
(+-)-cis-1-Acetyl-4-(P-((2-(2,4-dichlorophenyl)-2-(imidazol-1- ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
(2S,4R)-1-Acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
(2S,4R)-ketoconazole|COR-003|COR003|Recorlev®
1-[4-[4-[[2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL]METHOXY]PHENYL]-1-PIPERAZINYL]ETHANONE
1-ACETYL-4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
ABBR KTC
cis-1-Acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H- imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-ketoconazol
COR003
COR-003
DAKTARIN GOLD
DAKTARIN INTENSIV
DANDRAZOL
DANDRID
EXTINA
Fungarest
Fungoral
J02AB02
Janssen brand OF ketoconazole
KETOCONAZOL
Ketoconazole
|
Ketoconazole janssen brand
KETOCONAZOLUM
Ketoderm
Ketoisdin
KETOPINE
KETOSIDIN
KETOZOLE
LEVOKETOCONAZOLE
Nizoral
NIZORAL A-D
Nizoral®|R-41400
NIZORELLE
NSC 317629
NSC-317629
Orifungal m
Panfungol
Piperazine
R-41400
SID456469
Xolegel
|
|
42 |
|
Gentian violet cation |
Approved |
Phase 3 |
|
14426-25-6, 7438-46-2 |
3468 11057 |
Synonyms:
ANILINE VIOLET
BASIC VIOLET 3
BASIC VIOLET BN
Crystal violet
Crystal violet carbocation
Crystal violet ion(1)
Crystal violet(1+)
GENAPAX
GENTIAN VIOLET
Gentian violet carbocation
Gentian violet cation
Gentian violet(1+)
GENTIAVERM
GNF-PF-880
GV 11
|
GVS
HEXAMETHYL PARAROSANILINE CHLORIDE
HEXAMETHYL VIOLET
METHYL VIOLET
METHYL VIOLET 10B
Methylrosaniline
METHYLROSANILINE CHLORIDE
METHYLROSANILINE CL
Methylrosanilinium
METHYLROSANILINIUM CHLORIDE
METHYLROSANILINIUM CL
NSC-3090
PYOKTANIN
VIOCID
|
|
43 |
|
Itraconazole |
Approved, Investigational |
Phase 3 |
|
84625-61-6 |
55283 |
Synonyms:
ITC
ITCZ
Itraconazol
ITRACONAZOLE
Itraconazole janssen brand
Itraconazolum
ITRAZOLE
Itrizole
ITZ
Janssen brand OF itraconazole
Janssen cilag brand OF itraconazole
|
Janssen-cilag brand OF itraconazole
ONMEL
Oriconazole
Orungal
R-51211
SPORANOS
Sporanox
SPORANOX I.V.
SPORANOX-PULSE
TOLSURA
|
|
44 |
|
Isavuconazole |
Approved, Investigational |
Phase 3 |
|
241479-67-4 |
21937662 |
Synonyms:
isavuconazol
Isavuconazole
|
|
|
45 |
|
Benzocaine |
Approved, Investigational |
Phase 3 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
46 |
|
Tannic acid |
Approved |
Phase 3 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
47 |
|
Tetracycline |
Approved, Vet_approved, Withdrawn |
Phase 3 |
|
60-54-8 |
5353990 |
Synonyms:
(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
Abramycin
Achromycin
ACHROMYCIN V
Anhydrotetracycline
CYCLOPAR
Deschlorobiomycin
E701
ECONOMYCIN
Liquamycin
NSC-108579
PANMYCI DONT CAREIQUAMYCIN
PANMYCIN
Sumycin
|
SUPRAMYCIN
SUSTAMYCIN
TC
TETRABID ORGANON
Tetracyclin
TETRACYCLINE
TÉTRACYCLINE
Tetracycline HCL
Tetracyclinum
TETRACYN
Tetrazyklin
Tsiklomitsin
VETQUAMYCIN
|
|
48 |
|
Simethicone |
Approved |
Phase 3 |
|
8050-81-5 |
|
Synonyms:
ANTIFOAM A
ANTIFOAM AF
GAS-X
MYLANTA GAS RELIEF
MYLICON INFANT'S DROPS
SENTRY SIMETHICONE
|
SENTRY SIMETHICONE EMULSION
SIMETHICONE
Simeticona
Simeticone
Siméticone
Simeticonum
|
|
49 |
|
Ibrexafungerp |
Approved, Investigational |
Phase 3 |
|
1207753-03-4 |
75163792 |
Synonyms:
|
50 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 3 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
Interventional clinical trials:
(show top 50)
(show all 272)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Pilot Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID as Assessed by the Development of Laryngitis and Oropharyngeal Candidiasis in Adults With Mild Persistent Asthma |
Unknown status |
NCT00235053 |
Phase 4 |
fluticasone/salmeterol DISKUS 250/50 |
2 |
Diagnosis of Pulmonary Candidiasis |
Unknown status |
NCT00537888 |
Phase 4 |
fluconazole |
3 |
Fluconazole Prophylaxis of Thrush in AIDS |
Completed |
NCT00001542 |
Phase 4 |
fluconazole |
4 |
Oral Candidiasis in HIV Infected Individuals in Tanzania |
Completed |
NCT00553137 |
Phase 4 |
fluconazole |
5 |
A Phase IV Randomized Study of the Use of Fluconazole as Chronic Suppressive Therapy Versus Episodic Therapy in HIV Positive Subjects With Recurrent Oropharyngeal Candidiasis |
Completed |
NCT00000951 |
Phase 4 |
Fluconazole |
6 |
Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin®) and 100 mg Clotrimazole (Canesten®) for the Treatment of Vulvovaginal Candidiasis |
Completed |
NCT02242695 |
Phase 4 |
Fluomizin vaginal tablets;Canesten vaginal tablets |
7 |
CRITIC: Phase II Pilot Multicenter Study on Efficacy and Safety of Liposomal Amphotericin B (AmBisome®) at 2 mg/kg/Day in the Treatment of Candidemia and Invasive Candidiasis in Non-Neutropenic Patients |
Completed |
NCT00670657 |
Phase 4 |
AmBisome |
8 |
Open-Label, Non-Comparative, Study Of Intravenous Anidulafungin, Followed Optionally By Oral Voriconazole, For Treatment Of Documented Candidemia/Invasive Candidiasis In Hospitalized Patients |
Completed |
NCT00548262 |
Phase 4 |
Anidulafungin;Voriconazole |
9 |
Epidemiological Study About the Clinical and Microbiological Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis. |
Completed |
NCT02248506 |
Phase 4 |
|
10 |
A Randomized, Double-blind, Placebo Controlled Trial of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in High-risk Adults in the Critical Care Setting |
Completed |
NCT00520234 |
Phase 4 |
Caspofungin;Normal Saline |
11 |
Phase IV Open Label Non Comparative Trial Of IV Anidulafungin Followed By Oral Azole Therapy For The Treatment Of Candidemia And Invasive Candidiasis |
Completed |
NCT00496197 |
Phase 4 |
Eraxis (anidulafungin);Diflucan (fluconazole);Vfend (voriconazole) |
12 |
Pharmacokinetics and Optimal Dosage of Caspofungin in Critically Ill Patients With Suspected Invasive Candidiasis |
Completed |
NCT01994096 |
Phase 4 |
Caspofungin |
13 |
Vaginal Imaging Study to Evaluate the Effect of Exercise on the Distribution of Miconozole Nitrate OVULE |
Completed |
NCT00194324 |
Phase 4 |
Miconazole nitrate |
14 |
A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Micafungin (50 mg/Vial) After Intravenous Infusion of 50 mg Micafungin in Healthy Volunteers Under Fasting Conditions |
Completed |
NCT05496725 |
Phase 4 |
Micafungin |
15 |
A Randomized, Parallel-group Study of Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe |
Completed |
NCT02180100 |
Phase 4 |
Terconazole Vaginal Suppository;Fluconazole |
16 |
An Case-controlled Randomized Study to the Efficacy of Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis |
Completed |
NCT02180828 |
Phase 4 |
Clotrimazole vaginal tablet;Fluconazole |
17 |
Pharmacokinetics of Micafungin in Patients of Intensive Care Units |
Completed |
NCT02164890 |
Phase 4 |
|
18 |
Prospective 2-Year Longitudinal Study to Assess for Miconazole Resistance in Candida Spp. With Repeated Treatment Courses of 0.25% Miconazole Nitrate Ointment in Neonates and Infants up to 1 Year of Age With Recurrent Moderate-Severe Diaper Dermatitis Complicated by Cutaneous Candidiasis |
Completed |
NCT00702507 |
Phase 4 |
0.25 % Miconazole Nitrate Ointment |
19 |
Effectiveness and Safety of Daktacort Feminine Care Cream in the Treatment of Vulvar Candidiasis |
Completed |
NCT01769339 |
Phase 4 |
Miconazole plus Hydrocortisone |
20 |
A Pilot Study for the Use of Biomarkers and Early Treatment of Invasive Candidiasis in ICU Patients |
Completed |
NCT01734525 |
Phase 4 |
Anidulafungin |
21 |
Multicenter Pilot Study to Compare the Efficacy of a Combination of Vaginal Capsules With Acid Boric, L.Gasseri and L.Rhamnosus Versus the Reference Medication in Patients With Vaginal Candidiasis or Bacterial Vaginosis |
Completed |
NCT02860845 |
Phase 4 |
Antibiotic (Clindamycin);Antifungal (Clotrimazole) |
22 |
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration (FOLIA) |
Completed |
NCT04122560 |
Phase 4 |
Fluconazole 200mg tab;Fluconazole 2 MG/ML |
23 |
An Open Label, Non-comparative, Multicenter Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infection |
Completed |
NCT00647907 |
Phase 4 |
Voriconazole |
24 |
Invasive Fungal Infection in Liver Transplant Recipients: A Randomized Double-Blind Trial Comparing AmBisome and Fluconazole in the High Risk Group and an Observational Cohort Study in the Low Risk |
Completed |
NCT00001107 |
Phase 4 |
Fluconazole;AmBisome |
25 |
A National, Multi-central, Open-label, Single-arm, Phase IV Study to Evaluate Efficacy and Safety of Gynomax® XL Ovule in the Treatment of Trichomonal Vaginitis, Bacterial Vaginosis, Candidal Vulvovaginitis and Mixed Vaginal Infections |
Completed |
NCT03839875 |
Phase 4 |
Gynomax® XL Vaginal Ovule |
26 |
The Role of Oral Nystatin Prophylaxis in ICU Surgical/Trauma Patients |
Completed |
NCT01495039 |
Phase 4 |
Nystatin |
27 |
Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal Infection |
Recruiting |
NCT03717623 |
Phase 4 |
Posaconazole pharmacokinetics |
28 |
A Prospective, Case-controlled Randomized Study of Human Reproductive Tract Active Lactobacillus in Adjuvant Treatment of Recurrent Vulvovaginal Candidiasis. |
Recruiting |
NCT04699240 |
Phase 4 |
clotrimazole vaginal tablets;Clotrimazole vaginal tablets+ Lactobacillus |
29 |
A Randomized Controlled Trial to Compare the Efficacy of a Medical Grade Honey Formulation (L-Mesitran®) and Fluconazol (Diflucan®) for the Treatment of Recurrent Vulvovaginal Candidiasis |
Not yet recruiting |
NCT04626258 |
Phase 4 |
Fluconazole |
30 |
Multicenter Study to Compare Two Diagnostic Tests (1,3-β-D-glucan vs Blood Culture) in Critically Ill Patients With Suspected Invasive CAndidiasis Hospitalized in Internal Medicine Wards and Who Are Currently Timely Treated With Echinocandin (Micafungin) |
Terminated |
NCT03906916 |
Phase 4 |
Micafungin |
31 |
A Multi-center, Open-label, Non-comparative Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia (CFDA Commitment) |
Terminated |
NCT01982071 |
Phase 4 |
Micafungin |
32 |
A Multi-center, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp |
Terminated |
NCT02646800 |
Phase 4 |
Micafungin |
33 |
A Randomized Comparative Study of Fluconazole Versus Micafungin for the Treatment of Candida Bloodstream Infection in Non-Neutropenic Patients |
Withdrawn |
NCT00304772 |
Phase 4 |
Fluconazole;Micafungin |
34 |
Ketoconazole In Situ Gel Versus Terconazole Cream for Treatment of Vaginal Candidiasis |
Unknown status |
NCT03473418 |
Phase 3 |
Ketoconazole;Terconazole |
35 |
"A Multi-Centre, Randomized, Double Blind, Parallel-Group, Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Generic Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) to Clotrimazole Troche/Lozenges ® 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis ". |
Unknown status |
NCT02635438 |
Phase 3 |
Unique Pharmaceutical Laboratories, India;Roxane Laboratories Inc., USA |
36 |
Fluconazole Versus Micafungin in Neonates With Suspected or Culture-proven Candidiasis: a Randomized Pharmacokinetic and Safety Study (TINN Project - Treat Infections iN Neonates) |
Unknown status |
NCT02145832 |
Phase 2, Phase 3 |
Fluconazole;Micafungin |
37 |
Prospective Multicentre Randomized Double-blind Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis |
Unknown status |
NCT03580733 |
Phase 3 |
caspofungin antifungal therapy |
38 |
Phase III, Open Label, Randomized, Multicenter Study to Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, Compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vaginal Cream for the Treatment of Bacterial Vaginosis and Candidiasis Isolatedly or in Association (Mixed-Type Vaginosis) |
Unknown status |
NCT00889356 |
Phase 3 |
Clindamycin 100mg and Ketoconazole 400mg;Tetracycline 100mg and Amphotericin B 50mg |
39 |
A Phase 3, Randomized, Double-Blind, Comparative Trial of Two Dosing Regimens of Micafungin (FK463) Versus Caspofungin for the Treatment of Esophageal Candidiasis |
Completed |
NCT00665639 |
Phase 3 |
micafungin;caspofungin |
40 |
A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis |
Completed |
NCT00666185 |
Phase 3 |
Micafungin;Fluconazole |
41 |
A Comparison of Gentian Violet Mouth Washes, Nystatin Drops and Ketoconazole Tabs in the Treatment of Oropharyngeal Candidiasis |
Completed |
NCT00128323 |
Phase 3 |
Gentian violet 1% solution;Gentian violet 0.00165% solution;Nystatin solution |
42 |
Randomized, Controlled Trial of SCH 56592 Oral Suspension Versus Fluconazole Suspension in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients |
Completed |
NCT00002446 |
Phase 3 |
Posaconazole;Fluconazole |
43 |
A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 |
Completed |
NCT00001812 |
Phase 3 |
Nystatin |
44 |
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic in Elderly People |
Completed |
NCT02818803 |
Phase 3 |
Miconazole |
45 |
A Prospective Randomized, Blinded Parallel Group Study of Clotrimazole Troches vs. Mycelex® Troches (10 mg Troche Five Times a Day for 14 Days) in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis |
Completed |
NCT02184351 |
Phase 3 |
Roxanes's clotrimazole troches;Mycelex® troches |
46 |
A Non-comparative, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Acetate (MK-0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults |
Completed |
NCT00635648 |
Phase 3 |
caspofungin acetate |
47 |
Phase 3, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules vs Fluconazole and Placebo in Treatment of Acute Vulvovaginal Candidiasis in Subjects With Recurrent Vulvovaginal Candidiasis |
Completed |
NCT03840616 |
Phase 3 |
Oteseconazole (VT-1161) 150mg capsule;Fluconazole 150mg capsule;Placebo |
48 |
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections |
Completed |
NCT00413218 |
Phase 3 |
Isavuconazole;Caspofungin;Voriconazole |
49 |
Open-Label, Non-Comparative, Study Of Intravenous Anidulafungin, Followed Optionally By Oral Voriconazole Or Fluconazole Therapy, For Treatment Of Documented Candidemia/Invasive Candidiasis In Intensive Care Unit Patient Populations |
Completed |
NCT00689338 |
Phase 3 |
Anidulafungin;Fluconazole;Voriconazole |
50 |
Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis. International Phase III, Randomised, Multi-centre, Parallel-group, Two Arm, Double-blind Superiority Trial Versus Placebo. |
Completed |
NCT02251093 |
Phase 3 |
Lcr Regenerans;Placebo |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Chlorhexidine
chlorhexidine gluconate
Clotrimazole
Fluconazole
|
Flucytosine
Itraconazole
Ketoconazole
NYSTATIN PWDR
|
|